BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh S, Osna NA, Kharbanda KK. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. World J Gastroenterol 2017; 23(36): 6549-6570 [PMID: 29085205 DOI: 10.3748/wjg.v23.i36.6549] [Cited by in CrossRef: 123] [Cited by in F6Publishing: 132] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Trampuž SR, van Riet S, Nordling Å, Ingelman-Sundberg M. The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids. Cells 2023;12. [PMID: 36672237 DOI: 10.3390/cells12020302] [Reference Citation Analysis]
2 Zhu L, Xu J, Li H, Li J, Cheng M, Niu X, Jia P, Liu J, Huang C, Lv X, Li J. Berberine Ameliorates Abnormal Lipid Metabolism via the Adenosine Monophosphate–Activated Protein Kinase/Sirtuin 1 Pathway in Alcohol-Related Liver Disease. Laboratory Investigation 2023. [DOI: 10.1016/j.labinv.2022.100041] [Reference Citation Analysis]
3 Suh JY, Lee HJ, Sim DY, Park JE, Ahn CH, Park SY, Shin N, Kim B, Shim BS, Kim SH. Hypolipogenic effects of Icariside E4 via phosphorylation of AMPK and inhibition of MID1IP1 in HepG2 cells. Phytother Res 2023;37:7-14. [PMID: 35916211 DOI: 10.1002/ptr.7584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Patel D, Desai C, Singh D, Soppina V, Parwani K, Patel F, Mandal P. Synbiotic Intervention Ameliorates Oxidative Stress and Gut Permeability in an In Vitro and In Vivo Model of Ethanol-Induced Intestinal Dysbiosis. Biomedicines 2022;10. [PMID: 36552041 DOI: 10.3390/biomedicines10123285] [Reference Citation Analysis]
5 Wei M, Li T, Cao H, He H, Yang C, Yin Y, Lu H, Novák P, Zhang K, Gao Y. The effects of scoparone on alcohol and high-fat diet-induced liver injury revealed by RNA sequencing. Biomedicine & Pharmacotherapy 2022;155:113770. [DOI: 10.1016/j.biopha.2022.113770] [Reference Citation Analysis]
6 Kitano A, Norikura T, Matsui-Yuasa I, Shimakawa H, Kamezawa M, Kojima-Yuasa A. Phosphodiesterase 4 mRNA Level Suppression is Important for Extract of Black Carrot to Protect Against Hepatic Injury Induced by Ethanol. J Med Food 2022. [PMID: 36201260 DOI: 10.1089/jmf.2021.K.0186] [Reference Citation Analysis]
7 Ding S, Wang P, Pang X, Zhang L, Qian L, Jia X, Chen W, Ruan S, Sun L. The new exploration of pure total flavonoids extracted from Citrus maxima (Burm.) Merr. as a new therapeutic agent to bring health benefits for people. Front Nutr 2022;9:958329. [PMID: 36276813 DOI: 10.3389/fnut.2022.958329] [Reference Citation Analysis]
8 Warner JB, Guenthner SC, Hardesty JE, McClain CJ, Warner DR, Kirpich IA. Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease. World J Gastroenterol 2022; 28(36): 5280-5299 [DOI: 10.3748/wjg.v28.i36.5280] [Reference Citation Analysis]
9 Lee S, Chung K, Son S, Lee SY, Jang DS, Lee J, Kim H, Na C, Lee S, Lee K. A Botanical Mixture Consisting of Inula japonica and Potentilla chinensis Relieves Obesity via the AMPK Signaling Pathway in 3T3-L1 Adipocytes and HFD-Fed Obese Mice. Nutrients 2022;14:3685. [DOI: 10.3390/nu14183685] [Reference Citation Analysis]
10 Zhang Q, Wen J, Zhou J, Zhang B. Missing-view completion for fatty liver disease detection. Computers in Biology and Medicine 2022. [DOI: 10.1016/j.compbiomed.2022.106097] [Reference Citation Analysis]
11 Song L, Li M, Feng C, Sa R, Hu X, Wang J, Yin X, Qi C, Dong W, Yang J. Protective effect of curcumin on zebrafish liver under ethanol-induced oxidative stress. Comp Biochem Physiol C Toxicol Pharmacol 2022;258:109360. [PMID: 35523403 DOI: 10.1016/j.cbpc.2022.109360] [Reference Citation Analysis]
12 Chen R, Lian Y, Wen S, Li Q, Sun L, Lai X, Zhang Z, Zhu J, Tang L, Xuan J, Yuan E, Sun S. Shibi Tea (Adinandra nitida) and Camellianin A Alleviate CCl4-Induced Liver Injury in C57BL-6J Mice by Attenuation of Oxidative Stress, Inflammation, and Apoptosis. Nutrients 2022;14:3037. [DOI: 10.3390/nu14153037] [Reference Citation Analysis]
13 Guo F, Chen R, Kong L, Wei P, Liu Z, Wang X, Hao H, Lu Y, Hu W. Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular disease. Hepatol Int 2022. [PMID: 35849258 DOI: 10.1007/s12072-022-10387-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Li Y, Wei M, Yuan Q, Liu Y, Tian T, Hou L, Zhang J. MyD88 in hepatic stellate cells promotes the development of alcoholic fatty liver via the AKT pathway. J Mol Med (Berl) 2022;100:1071-85. [PMID: 35708745 DOI: 10.1007/s00109-022-02196-1] [Reference Citation Analysis]
15 Xie F, Zhong Y, Wang D, So KF, Xiao J, Lv Y. Metformin protects against ethanol-induced liver triglyceride accumulation by the LKB1/AMPK/ACC pathway. Mol Biol Rep 2022. [PMID: 35733070 DOI: 10.1007/s11033-022-07610-y] [Reference Citation Analysis]
16 Alugoju P, Krishna Swamy VKD, Anthikapalli NVA, Tencomnao T. Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review. Crit Rev Food Sci Nutr 2022;:1-66. [PMID: 35708049 DOI: 10.1080/10408398.2022.2084600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Julià H, Benaiges D, Pedro-botet J. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica (English Edition) 2022;158:550-555. [DOI: 10.1016/j.medcle.2022.05.009] [Reference Citation Analysis]
18 Lai X, Wang X, Wen S, Sun L, Chen R, Zhang Z, Li Q, Cao J, Lai Z, Li Z, Sun S, Liu X. Six Types of Tea Reduce Acute Alcoholism in Mice by Enhancing Ethanol Metabolism, Suppressing Oxidative Stress and Inflammation. Front Nutr 2022;9:848918. [DOI: 10.3389/fnut.2022.848918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Jarmakiewicz-czaja S, Sokal A, Pardak P, Filip R, Granito A. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-13. [DOI: 10.1155/2022/4344905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Liu X, Yang G, Sun T, Tao L, Shen D, Zhang W, Zhang J, Xue D, Chen B, Wu L, Liu C, Ma W. Glial cell line-derived neurotrophic factor contributes to alcoholic-induced liver injury by regulating the NF-κB pathway. Alcohol Clin Exp Res 2022;46:724-35. [PMID: 35338490 DOI: 10.1111/acer.14815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Prasomthong J, Limpeanchob N, Daodee S, Chonpathompikunlert P, Tunsophon S. Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1/Akt and Nrf2 signaling pathways in rats fed a high fat diet. Sci Rep 2022;12:7022. [PMID: 35487948 DOI: 10.1038/s41598-022-11027-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Hu Q, Liao W, Zhang Z, Shi S, Hou S, Ji N, Zhang X, Zhang Q, Liao Y, Li L, Zhu Z, Chen Y, Chen J, Yu F, Yang Q, Xiao H, Fu C, Du H, Wang Q, Cao H, Xiao H, Li R. The hepatoprotective effects of plant-based foods based on the "gut-liver axis": a prospective review. Crit Rev Food Sci Nutr 2022;:1-27. [PMID: 35466839 DOI: 10.1080/10408398.2022.2064423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Fitzgerald PJ. Is There a Novel Biosynthetic Pathway in Mice That Converts Alcohol to Dopamine, Norepinephrine and Epinephrine? Molecules 2022;27:2726. [DOI: 10.3390/molecules27092726] [Reference Citation Analysis]
24 Guo M, Gu L, Hui H, Li X, Jin L. Extracts of Dracocephalum tanguticum Maxim Ameliorate Acute Alcoholic Liver Disease via Regulating Transcription Factors in Mice. Front Pharmacol 2022;13:830532. [PMID: 35370722 DOI: 10.3389/fphar.2022.830532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bhandari P, Sapra A, Ajmeri MS, Albers CE, Sapra D. Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami? Cureus. [DOI: 10.7759/cureus.23806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Lu Y, Shao M, Xiang H, Wang J, Ji G, Wu T. Qinggan Huoxue Recipe Alleviates Alcoholic Liver Injury by Suppressing Endoplasmic Reticulum Stress Through LXR-LPCAT3. Front Pharmacol 2022;13:824185. [DOI: 10.3389/fphar.2022.824185] [Reference Citation Analysis]
27 Ma H, Ma Y, Dawa Z, Yao Y, Wang M, Zhang K, Zhu C, Liu F, Lin C. Diterpenoid Alkaloids Isolated from Delphinium brunonianum and Their Inhibitory Effects on Hepatocytes Lipid Accumulation. Molecules 2022;27:2257. [PMID: 35408656 DOI: 10.3390/molecules27072257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Wang Y, Wang Y, Li F, Zou J, Li X, Xu M, Yu D, Ma Y, Huang W, Sun X, Zhang Y. Psoralen Suppresses Lipid Deposition by Alleviating Insulin Resistance and Promoting Autophagy in Oleate-Induced L02 Cells. Cells 2022;11:1067. [PMID: 35406631 DOI: 10.3390/cells11071067] [Reference Citation Analysis]
29 Julià H, Benaiges D, Pedro-botet J. Bariatric surgery and non-alcoholic fatty liver disease. Medicina Clínica 2022. [DOI: 10.1016/j.medcli.2021.12.003] [Reference Citation Analysis]
30 Zhao F, Ke J, Pan W, Pan H, Shen M. Synergistic effects of ISL1 and KDM6B on non-alcoholic fatty liver disease through the regulation of SNAI1. Mol Med 2022;28:12. [PMID: 35100965 DOI: 10.1186/s10020-021-00428-7] [Reference Citation Analysis]
31 Bell AS, O’connell EM, Lohoff FW. Cholesterol and alcohol. Cholesterol 2022. [DOI: 10.1016/b978-0-323-85857-1.00036-5] [Reference Citation Analysis]
32 Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 2022;399:61-116. [PMID: 34863359 DOI: 10.1016/S0140-6736(21)01701-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 66] [Article Influence: 53.0] [Reference Citation Analysis]
33 Patel P, Sivaiah B, Patel R. Relevance of Frequent Pattern (FP)-Growth-Based Association Rules on Liver Diseases. Intelligent Systems 2022. [DOI: 10.1007/978-981-19-0901-6_58] [Reference Citation Analysis]
34 Muriel P. Alcohol-induced liver fibrosis. Hepatic Fibrosis 2022. [DOI: 10.1016/b978-0-323-99764-5.00008-1] [Reference Citation Analysis]
35 Maev IV, Bueverov AO, Volnukhin AV. Efficacy and Safety of a Fixed Combination of Glycyrrhizic Acid and Essential Phospholipids in Non-Alcoholic Fatty and Alcoholic Liver Disease: Results from Randomized Placebo-Controlled Trials. Annals RAMS 2021;76:595-603. [DOI: 10.15690/vramn1576] [Reference Citation Analysis]
36 Wang C, Ma C, Gong L, Dai S, Li Y. Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms. Eur J Pharmacol 2021;912:174604. [PMID: 34743980 DOI: 10.1016/j.ejphar.2021.174604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
37 Gibert-Ramos A, Sanfeliu-Redondo D, Aristu-Zabalza P, Martínez-Alcocer A, Gracia-Sancho J, Guixé-Muntet S, Fernández-Iglesias A. The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer. Cancers (Basel) 2021;13:5719. [PMID: 34830874 DOI: 10.3390/cancers13225719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Shan MY, Dai Y, Ren XD, Zheng J, Zhang KB, Chen B, Yan J, Xu ZH. Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis. J Integr Med 2021;19:545-54. [PMID: 34686466 DOI: 10.1016/j.joim.2021.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Chen LJ, Lin XX, Guo J, Xu Y, Zhang SX, Chen D, Zhao Q, Xiao J, Lian GH, Peng SF, Guo D, Yang H, Shu Y, Zhou HH, Zhang W, Chen Y. Lrp6 Genotype affects Individual Susceptibility to Nonalcoholic Fatty Liver Disease and Silibinin Therapeutic Response via Wnt/β-catenin-Cyp2e1 Signaling. Int J Biol Sci 2021;17:3936-53. [PMID: 34671210 DOI: 10.7150/ijbs.63732] [Reference Citation Analysis]
40 Patel F, Parwani K, Rao P, Patel D, Rawal R, Mandal P. Prophylactic Treatment of Probiotic and Metformin Mitigates Ethanol-Induced Intestinal Barrier Injury: In Vitro, In Vivo, and In Silico Approaches. Mediators Inflamm 2021;2021:5245197. [PMID: 34616233 DOI: 10.1155/2021/5245197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Yang Y, Cho JH. Higher Weight Variability Could Bring You a Fatty Liver. Endocrinol Metab (Seoul) 2021;36:766-8. [PMID: 34474514 DOI: 10.3803/EnM.2021.403] [Reference Citation Analysis]
42 Bortnikova VV, Karabaeva VV, Krepkova LV, Mizina PG, Babenko AN, Mikheeva NS, Karabaeva ON. A Retrospective Analysis of the Clinical Studies of a Drug "Flakozid" in the Treatment of Diseases of the Hepatobiliary System. Razrabotka i registraciâ lekarstvennyh sredstv 2021;10:100-4. [DOI: 10.33380/2305-2066-2021-10-3-100-104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Nafshi R, Lezon TR. Predicting the Effects of Drug Combinations Using Probabilistic Matrix Factorization. Front Bioinform 2021;1:708815. [DOI: 10.3389/fbinf.2021.708815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Wang R, Mu J. Arbutin attenuates ethanol-induced acute hepatic injury by the modulation of oxidative stress and Nrf-2/HO-1 signaling pathway. J Biochem Mol Toxicol 2021;:e22872. [PMID: 34346143 DOI: 10.1002/jbt.22872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Balkrishna A, Gohel V, Singh R, Bhattacharya K, Varshney A. Livogrit ameliorates acetaldehyde-induced steatosis in HepG2 cells through modulation of lipogenesis and β-oxidation pathways. Phytomedicine Plus 2021;1:100067. [DOI: 10.1016/j.phyplu.2021.100067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
46 Huang X, Dubiel D, Dubiel W. The COP9 Signalosome Variant CSNCSN7A Stabilizes the Deubiquitylating Enzyme CYLD Impeding Hepatic Steatosis. Livers 2021;1:116-31. [DOI: 10.3390/livers1030011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Kong L, Dong R, Huang K, Wang X, Wang D, Yue N, Wang C, Sun P, Gu J, Luo H, Liu K, Wu J, Sun H, Meng Q. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR. Phytomedicine 2021;90:153629. [PMID: 34304130 DOI: 10.1016/j.phymed.2021.153629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
48 Chang BY, Kim HJ, Kim TY, Kim SY. Enzyme-Treated Zizania latifolia Extract Protects against Alcohol-Induced Liver Injury by Regulating the NRF2 Pathway. Antioxidants (Basel) 2021;10:960. [PMID: 34203789 DOI: 10.3390/antiox10060960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
49 Paek S, Lee S, Park JS, Kim J, Park D. The Effects of Turmeric Intake Alone or in Combination with Resistance Training on Liver Enzymes in Adult Men. Exerc Sci 2021;30:183-191. [DOI: 10.15857/ksep.2021.30.2.183] [Reference Citation Analysis]
50 Arumugam MK, Paal MC, Donohue TM Jr, Ganesan M, Osna NA, Kharbanda KK. Beneficial Effects of Betaine: A Comprehensive Review. Biology (Basel) 2021;10:456. [PMID: 34067313 DOI: 10.3390/biology10060456] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
51 Song X, Sun W, Cui W, Jia L, Zhang J. A polysaccharide of PFP-1 from Pleurotus geesteranus attenuates alcoholic liver diseases via Nrf2 and NF-κB signaling pathways. Food Funct 2021;12:4591-605. [PMID: 33908547 DOI: 10.1039/d1fo00310k] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
52 Talawar ST, Gangappa K, Gurunathan S, V.p M, Gurusiddaiah SK. Sterol Ferulate Rich Wheat Bran Oil Concentrate Prevents Liver Damage in MAFLD Mouse Model by Modulating FAS and PCSK9. ACS Food Sci Technol 2021;1:644-652. [DOI: 10.1021/acsfoodscitech.0c00156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Pan Q, Han T, Li G. Novel insights into the roles of tRNA-derived small RNAs. RNA Biol 2021;:1-11. [PMID: 33998370 DOI: 10.1080/15476286.2021.1922009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
54 Zhao R, Xiang B, Dolinsky VW, Xia M, Shen GX. Saskatoon berry powder reduces hepatic steatosis and insulin resistance in high fat-high sucrose diet-induced obese mice. J Nutr Biochem 2021;95:108778. [PMID: 34004342 DOI: 10.1016/j.jnutbio.2021.108778] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
55 Ivashkin VT, Maevskaya MV, Shirokova EN, Maev IV, Samsonov AA, Sas EI, Palgova LK, Starostin K. Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies. Drugs Real World Outcomes 2021;8:369-82. [PMID: 33993460 DOI: 10.1007/s40801-021-00250-x] [Reference Citation Analysis]
56 Jiang ZB, Gao J, Chai YH, Li W, Luo YF, Chen YZ. Astragaloside alleviates alcoholic fatty liver disease by suppressing oxidative stress. Kaohsiung J Med Sci 2021;37:718-29. [PMID: 33973356 DOI: 10.1002/kjm2.12390] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
57 Kamboj P, Sarkar S, Gupta SK, Bisht N, Kumari D, Alam MJ, Barge S, Kashyap B, Deka B, Bharadwaj S, Rahman S, Dutta PP, Borah JC, Talukdar NC, Banerjee SK, Kumar Y. Methanolic Extract of Lysimachia Candida Lindl. Prevents High-Fat High-Fructose-Induced Fatty Liver in Rats: Understanding the Molecular Mechanism Through Untargeted Metabolomics Study. Front Pharmacol 2021;12:653872. [PMID: 33935766 DOI: 10.3389/fphar.2021.653872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
58 Patel F, Parwani K, Patel D, Mandal P. Metformin and Probiotics Interplay in Amelioration of Ethanol-Induced Oxidative Stress and Inflammatory Response in an In Vitro and In Vivo Model of Hepatic Injury. Mediators Inflamm 2021;2021:6636152. [PMID: 33953643 DOI: 10.1155/2021/6636152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
59 Jain D, Torres R, Celli R, Koelmel J, Charkoftaki G, Vasiliou V. Evolution of the liver biopsy and its future. Transl Gastroenterol Hepatol 2021;6:20. [PMID: 33824924 DOI: 10.21037/tgh.2020.04.01] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
60 Yang L, Liu Q, Zhang H, Wang Y, Li Y, Chen S, Song G, Ren L. Silibinin improves nonalcoholic fatty liver by regulating the expression of miR‑122: An in vitro and in vivo study. Mol Med Rep 2021;23:335. [PMID: 33760189 DOI: 10.3892/mmr.2021.11974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Sodum N, Kumar G, Bojja SL, Kumar N, Rao CM. Epigenetics in NAFLD/NASH: Targets and therapy. Pharmacol Res 2021;167:105484. [PMID: 33771699 DOI: 10.1016/j.phrs.2021.105484] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
62 Kaufmann B, Reca A, Kim AD, Feldstein AE. Novel Mechanisms for Resolution of Liver Inflammation: Therapeutic Implications. Semin Liver Dis 2021;41:150-62. [PMID: 34107544 DOI: 10.1055/s-0041-1723031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 Köseoğlu D, Koparal SS, Özdemir Başer Ö, Berker D. Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study. Turk J Med Sci 2021;51:167-74. [PMID: 32892547 DOI: 10.3906/sag-2004-154] [Reference Citation Analysis]
64 Han SW, Wang XJ, Cui BS, Sun H, Chen H, Ferreira D, Li S, Hamann MT. Hepatoprotective Glucosyloxybenzyl 2-Hydroxy-2-isobutylsuccinates from Pleione yunnanensis. J Nat Prod 2021;84:738-49. [PMID: 33606538 DOI: 10.1021/acs.jnatprod.0c01117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
65 Subramaniyan V, Chakravarthi S, Jegasothy R, Seng WY, Fuloria NK, Fuloria S, Hazarika I, Das A. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy. Toxicol Rep 2021;8:376-85. [PMID: 33680863 DOI: 10.1016/j.toxrep.2021.02.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
66 Yang JY, Li M, Zhang CL, Liu D. Pharmacological properties of baicalin on liver diseases: a narrative review. Pharmacol Rep 2021;73:1230-9. [PMID: 33595821 DOI: 10.1007/s43440-021-00227-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
67 Kwong EK, Puri P. Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease. Transl Gastroenterol Hepatol 2021;6:3. [PMID: 33409398 DOI: 10.21037/tgh.2020.02.18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
68 Hu J, Yang S. Role of Etiology Therapy in Management of Variceal Hemorrhage in Liver Cirrhosis. Variceal Bleeding in Liver Cirrhosis 2021. [DOI: 10.1007/978-981-15-7249-4_4] [Reference Citation Analysis]
69 Xue C, Gu X, Li G, Bao Z, Li L. Mitochondrial Mechanisms of Necroptosis in Liver Diseases. Int J Mol Sci 2020;22:E66. [PMID: 33374660 DOI: 10.3390/ijms22010066] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
70 Li Z, Wang F, Liang B, Su Y, Sun S, Xia S, Shao J, Zhang Z, Hong M, Zhang F, Zheng S. Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduct Target Ther 2020;5:280. [PMID: 33273451 DOI: 10.1038/s41392-020-00349-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
71 Colletta C, Colletta A, Placentino G. Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease. J Diabetes Metab Disord 2020;19:883-94. [PMID: 33520810 DOI: 10.1007/s40200-020-00576-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Rashed ZE, Grasselli E, Khalifeh H, Canesi L, Demori I. Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease. Planta Med 2020. [PMID: 33142346 DOI: 10.1055/a-1273-3159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
73 Östlund C, Hernandez-Ono A, Shin JY. The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD. Biology (Basel) 2020;9:E338. [PMID: 33076344 DOI: 10.3390/biology9100338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
74 Mello A, Hsu MF, Koike S, Chu B, Cheng J, Yang J, Morisseau C, Torok NJ, Hammock BD, Haj FG. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease. Cell Mol Gastroenterol Hepatol 2021;11:815-30. [PMID: 33068774 DOI: 10.1016/j.jcmgh.2020.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
75 Elnagdy M, Barve S, McClain C, Gobejishvili L. cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease. Biomolecules 2020;10:E1433. [PMID: 33050657 DOI: 10.3390/biom10101433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
76 Jeong MS, Park S, Han EJ, Park SY, Kim MJ, Jung K, Cho S, Kim S, Yoon W, Ahn G, Kim K. Pinus thunbergii PARL leaf protects against alcohol-induced liver disease by enhancing antioxidant defense mechanism in BALB/c mice. Journal of Functional Foods 2020;73:104116. [DOI: 10.1016/j.jff.2020.104116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
77 Ye M, Xu M, Fan S, Zhang M, Zhou B, Yang S, Wei W, Ji C, Ji J, Ji F. Protective effects of three propolis-abundant flavonoids against ethanol-induced injuries in HepG2 cells involving the inhibition of ERK1/2-AHR-CYP1A1 signaling pathways. Journal of Functional Foods 2020;73:104166. [DOI: 10.1016/j.jff.2020.104166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
78 Ramos LF, Silva CM, Pansa CC, Moraes KCM. Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver. Expert Rev Gastroenterol Hepatol 2021;15:25-40. [PMID: 32892668 DOI: 10.1080/17474124.2020.1820321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
79 Jung I, Kim H, Moon S, Lee H, Kim B. Overview of Salvia miltiorrhiza as a Potential Therapeutic Agent for Various Diseases: An Update on Efficacy and Mechanisms of Action. Antioxidants (Basel) 2020;9:E857. [PMID: 32933217 DOI: 10.3390/antiox9090857] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
80 Yoon YH, Chen CM, Slater ME, Jung MK, White AM. Trends in Premature Deaths From Alcoholic Liver Disease in the U.S., 1999-2018. Am J Prev Med 2020;59:469-80. [PMID: 32863077 DOI: 10.1016/j.amepre.2020.04.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
81 Wang X, Chang X, Zhan H, Zhang Q, Li C, Gao Q, Yang M, Luo Z, Li S, Sun Y. Curcumin and Baicalin ameliorate ethanol-induced liver oxidative damage via the Nrf2/HO-1 pathway. J Food Biochem 2020;:e13425. [PMID: 32770697 DOI: 10.1111/jfbc.13425] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
82 Hsu MF, Koike S, Mello A, Nagy LE, Haj FG. Hepatic protein-tyrosine phosphatase 1B disruption and pharmacological inhibition attenuate ethanol-induced oxidative stress and ameliorate alcoholic liver disease in mice. Redox Biol 2020;36:101658. [PMID: 32769011 DOI: 10.1016/j.redox.2020.101658] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
83 Zhang H, Yang L, Wang Y, Huang W, Li Y, Chen S, Song G, Ren L. Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease. Life Sci 2020;257:118090. [PMID: 32679144 DOI: 10.1016/j.lfs.2020.118090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
84 Gao Y, Zhang S, Li J, Zhao J, Xiao Q, Zhu Y, Zhang J, Huang W. Effect and mechanism of ginsenoside Rg1-regulating hepatic steatosis in HepG2 cells induced by free fatty acid. Biosci Biotechnol Biochem 2020;84:2228-40. [PMID: 32654591 DOI: 10.1080/09168451.2020.1793293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
85 Tavakoli T, Zarban A, Hooshyar R, Salmani F, Tajik H. Improvement of thiol groups and total antioxidant capacity in patients with non-alcoholic fatty liver after treatment with pioglitazone. Arch Physiol Biochem 2020;:1-5. [PMID: 32608271 DOI: 10.1080/13813455.2020.1784953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
86 Grønkjær LL, Wernberg C, Lauridsen MM. Non-alcoholic fatty liver disease: the role of the nurse. Gastrointestinal Nursing 2020;18:S15-21. [DOI: 10.12968/gasn.2020.18.sup6.s15] [Reference Citation Analysis]
87 Ren J, Sha W, Shang S, Yuan E. Hepatoprotective peptides purified from Corbicula fluminea and its effect against ethanol‐induced LO2 cells injury. Int J Food Sci Technol 2021;56:352-61. [DOI: 10.1111/ijfs.14649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
88 Afsharinasab M, Mohammad-Sadeghipour M, Reza Hajizadeh M, Khoshdel A, Mirzaiey V, Mahmoodi M. The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease. Saudi J Biol Sci 2020;27:2031-7. [PMID: 32742180 DOI: 10.1016/j.sjbs.2020.04.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
89 Fernandez-Travieso JC, Rodriguez-Perez I, Ruenes-Domech C, lIlnait-Ferrer J, Fernandez-Dorta L, Mendoza-Castano S. Benefits of the Therapy With Abexol in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology Res 2020;13:73-80. [PMID: 32362966 DOI: 10.14740/gr1273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
90 Lv Y, So KF, Xiao J. Liver regeneration and alcoholic liver disease. Ann Transl Med 2020;8:567. [PMID: 32775368 DOI: 10.21037/atm.2020.02.168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
91 Lam S, Doran S, Yuksel HH, Altay O, Turkez H, Nielsen J, Boren J, Uhlen M, Mardinoglu A. Addressing the heterogeneity in liver diseases using biological networks. Brief Bioinform 2021;22:1751-66. [PMID: 32201876 DOI: 10.1093/bib/bbaa002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
92 Kirpich IA, Warner DR, Feng W, Joshi-Barve S, McClain CJ, Seth D, Zhong W, Zhou Z, Osna NA, Kharbanda KK. Mechanisms, biomarkers and targets for therapy in alcohol-associated liver injury: From Genetics to nutrition: Summary of the ISBRA 2018 symposium. Alcohol 2020;83:105-14. [PMID: 31129175 DOI: 10.1016/j.alcohol.2019.05.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
93 Li Y, Wang C, Jin Y, Chen H, Cao M, Li W, Luo H, Wu Z. Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed rats. Biomed Pharmacother 2020;126:109734. [PMID: 32114355 DOI: 10.1016/j.biopha.2019.109734] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
94 Gala KS, Vatsalya V. Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope. Cells 2020;9:E524. [PMID: 32106390 DOI: 10.3390/cells9030524] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
95 Dolin CE, Arteel GE. The Matrisome, Inflammation, and Liver Disease. Semin Liver Dis 2020;40:180-8. [PMID: 31910448 DOI: 10.1055/s-0039-3402516] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
96 Shi T, Wu L, Ma W, Ju L, Bai M, Chen X, Liu S, Yang X, Shi J. Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine. Evid Based Complement Alternat Med 2020;2020:8749564. [PMID: 31998400 DOI: 10.1155/2020/8749564] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
97 Lu J, Zhu X, Zhang C, Lu F, Lu Z, Lu Y. Co-expression of alcohol dehydrogenase and aldehyde dehydrogenase in Bacillus subtilis for alcohol detoxification. Food and Chemical Toxicology 2020;135:110890. [DOI: 10.1016/j.fct.2019.110890] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
98 Dolin CE, Sato T, Merchant ML, Arteel GE. Detecting Changes to the Extracellular Matrix in Liver Diseases. Extracellular Matrix Omics 2020. [DOI: 10.1007/978-3-030-58330-9_3] [Reference Citation Analysis]
99 Margalit M, Yeshua H, Gotlieb N, Zelber-sagi S. Detection of NAFLD/NASH in the General Population and in Primary Care Clinics. NAFLD and NASH 2020. [DOI: 10.1007/978-3-030-37173-9_2] [Reference Citation Analysis]
100 Khukhlina OS, Hryniuk OY, Antoniv AA. OXIDATIVE STRESS INTENSITY AND STATE OF SEPARATE ANTIOXIDANT PROTECTION FACTORS IN ANTRALE TREATMENT IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS, OBESITY, AND CHRONIC OBSTRUCTIVE LUNG DISEASE. EUMJ 2020;8:129-136. [DOI: 10.21272/eumj.2020;8(2):129-136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
101 Lachiondo-Ortega S, Mercado-Gómez M, Serrano-Maciá M, Lopitz-Otsoa F, Salas-Villalobos TB, Varela-Rey M, Delgado TC, Martínez-Chantar ML. Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis. Cells 2019;8:E1575. [PMID: 31817258 DOI: 10.3390/cells8121575] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
102 Hung YH, Kanke M, Kurtz CL, Cubitt RL, Bunaciu RP, Zhou L, White PJ, Vickers KC, Hussain MM, Li X, Sethupathy P. MiR-29 Regulates de novo Lipogenesis in the Liver and Circulating Triglyceride Levels in a Sirt1-Dependent Manner. Front Physiol 2019;10:1367. [PMID: 31736786 DOI: 10.3389/fphys.2019.01367] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
103 Federico A, Dallio M, Masarone M, Gravina AG, Di Sarno R, Tuccillo C, Cossiga V, Lama S, Stiuso P, Morisco F, Persico M, Loguercio C. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients. Oxid Med Cell Longev 2019;2019:8742075. [PMID: 31737175 DOI: 10.1155/2019/8742075] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
104 Kounakis K, Chaniotakis M, Markaki M, Tavernarakis N. Emerging Roles of Lipophagy in Health and Disease. Front Cell Dev Biol. 2019;7:185. [PMID: 31552248 DOI: 10.3389/fcell.2019.00185] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 18.3] [Reference Citation Analysis]
105 Zhao C, Liu L, Liu Q, Li F, Zhang L, Zhu F, Shao T, Barve S, Chen Y, Li X, McClain CJ, Feng W. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice. Mol Metab. 2019;29:145-157. [PMID: 31668386 DOI: 10.1016/j.molmet.2019.08.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
106 Parra-Robert M, Casals E, Massana N, Zeng M, Perramón M, Fernández-Varo G, Morales-Ruiz M, Puntes V, Jiménez W, Casals G. Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis. Biomolecules 2019;9:E425. [PMID: 31470518 DOI: 10.3390/biom9090425] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
107 Hormati A, Tooiserkany F, Mohammadbeigi A, Aliasl F, Moradi Dehnavi H. Effect of an Herbal Product on the Serum Level of Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blinded, Placebo-Controlled Trial. Iran Red Crescent Med J 2019;21. [DOI: 10.5812/ircmj.91024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
108 Chen X, Bian M, Jin H, Lian N, Shao J, Zhang F, Zheng S. Dihydroartemisinin attenuates alcoholic fatty liver through regulation of lipin-1 signaling. IUBMB Life 2019;71:1740-50. [PMID: 31265202 DOI: 10.1002/iub.2113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
109 Cho N, Lee Y, Kim K, Choi H, Kim S, Back Y, Moon B. A Review of Domestic Research on Traditional Korean Medicine for Alcoholic Liver Disease. J Int Korean Med 2019;40:458-477. [DOI: 10.22246/jikm.2019.40.3.458] [Reference Citation Analysis]
110 Cholankeril G, Gadiparthi C, Yoo ER, Dennis BB, Li AA, Hu M, Wong K, Kim D, Ahmed A. Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States. Transplantation 2019;103:131-9. [PMID: 30300285 DOI: 10.1097/TP.0000000000002471] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
111 Parizadeh SM, Parizadeh SA, Alizade-noghani M, Jafarzadeh-esfehani R, Ghandehari M, Mottaghi-moghaddam A, Goldani F, Khazaei M, Ghayour-mobarhan M, Ferns GA, Hassanian SM, Avan A. Association between non-alcoholic fatty liver disease and colorectal cancer. Expert Review of Gastroenterology & Hepatology 2019;13:633-41. [DOI: 10.1080/17474124.2019.1617696] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
112 Chatterjee S, Patra D, Chakraborti U, Sengupta D, Ghosh P, Basu A, Sadhukhan GC, Chowdhury KD. Association of p38MAPK‐p53‐Fas aggregation in S‐allyl cysteine mediated regulation of hepatocarcinoma. Environmental Toxicology 2019;34:928-40. [DOI: 10.1002/tox.22764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
113 Bai L, Li H. Innate immune regulatory networks in hepatic lipid metabolism. J Mol Med (Berl). 2019;97:593-604. [PMID: 30891617 DOI: 10.1007/s00109-019-01765-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
114 Albracht-Schulte K, Gonzalez S, Jackson A, Wilson S, Ramalingam L, Kalupahana NS, Moustaid-Moussa N. Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells. Nutrients 2019;11:E599. [PMID: 30871035 DOI: 10.3390/nu11030599] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
115 Seifert B. Hepatoprotectives and their use in general practice. Med Pro Praxi 2019;16:20-22. [DOI: 10.36290/med.2019.046] [Reference Citation Analysis]
116 Luo Z, Wu Q. Progress in Research on Nonalcoholic Fatty Liver and Gestational Diabetes. IJCM 2019;10:251-258. [DOI: 10.4236/ijcm.2019.104019] [Reference Citation Analysis]
117 Kim BH. The Protective Effects of Silbi-um Extract on the Alcoholic Liver Injury in Rats. JKOMOR 2018;18:74-82. [DOI: 10.15429/jkomor.2018.18.2.74] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
118 Maggi U, Iavarone M, Fabbi M, Yiu D, Fornoni G, Melada E, Dondossola D, Cantù P, Rossi G. Liver Transplantations and Brain Dead Donors With Alcohol Abuse. Transplant Proc 2018;50:3105-10. [PMID: 30577174 DOI: 10.1016/j.transproceed.2018.08.023] [Reference Citation Analysis]
119 Schwabe RF, Luedde T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat Rev Gastroenterol Hepatol 2018;15:738-52. [PMID: 30250076 DOI: 10.1038/s41575-018-0065-y] [Cited by in Crossref: 232] [Cited by in F6Publishing: 231] [Article Influence: 46.4] [Reference Citation Analysis]
120 Alsherbiny MA, Abd-Elsalam WH, El Badawy SA, Taher E, Fares M, Torres A, Chang D, Li CG. Ameliorative and protective effects of ginger and its main constituents against natural, chemical and radiation-induced toxicities: A comprehensive review. Food Chem Toxicol 2019;123:72-97. [PMID: 30352300 DOI: 10.1016/j.fct.2018.10.048] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
121 Sun J, Li B, Sun A, Zhao K, Ma Y, Zhao J, Pan H, Song Q, Wang Y, Yu C, Wang C, Zhang H, Zhang W, Kong C. Comprehensive analysis of aberrantly expressed profiles of messenger RNA in alcoholic liver disease. J Cell Biochem 2019;120:4248-54. [PMID: 30294942 DOI: 10.1002/jcb.27710] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Ok DP, Ko K, Bae JY. Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits. Lipids Health Dis 2018;17:207. [PMID: 30172252 DOI: 10.1186/s12944-018-0852-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
123 Petyaev IM, Chernyshova MP, Pristensky DV, Chalyk NE, Klochkov VA, Kyle NH, Bashmakov YK. Effect of Lycosome-Formulated Phosphatidylcholine on Parameters of Biological Oxidation after Single Intake of Moderate Amount of Alcohol. Advances in Preventive Medicine 2018;2018:1-11. [DOI: 10.1155/2018/5840451] [Reference Citation Analysis]
124 Cheng Q, Li YW, Yang CF, Zhong YJ, He H, Zhu FC, Li L. Methyl ferulic acid attenuates ethanol-induced hepatic steatosis by regulating AMPK and FoxO1 Pathways in Rats and L-02 cells. Chem Biol Interact 2018;291:180-9. [PMID: 29940154 DOI: 10.1016/j.cbi.2018.06.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
125 Svistunov AA, Osadchuk MA, Kireeva NV, Osadchuk MM. Optimizing therapy of liver diseases not associated with viral infection. Terapevticheskii arkhiv 2018;90:94-99. [DOI: 10.26442/terarkh2018902105-111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
126 Tong J, Sun CY, Yang LB, Kang YN. Clinical efficacy of tauroursodeoxycholic acid combined with S-adenosyl methionine in treatment of cholestasis in patients with compensated alcoholic cirrhosis. Shijie Huaren Xiaohua Zazhi 2018; 26(1): 31-35 [DOI: 10.11569/wcjd.v26.i1.31] [Reference Citation Analysis]
127 Colica C, Boccuto L, Abenavoli L. Silymarin: An option to treat non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23(47): 8437-8438 [PMID: 29309065 DOI: 10.3748/wjg.v23.i47.8437] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]